JESSE J GEIGER, the President of $MEDP, sold 31,707 shares of the company on 03-17-2026 for an estimated $14,436,197. We received data on the trade from a recent SEC filing. This was a sale of approximately 67.9% of their shares of this class of stock. Following this trade, they now own 15,000 shares of this class of $MEDP stock.
$MEDP Insider Trading Activity
$MEDP insiders have traded $MEDP stock on the open market 26 times in the past 6 months. Of those trades, 0 have been purchases and 26 have been sales.
Here’s a breakdown of recent trading of $MEDP stock by insiders over the last 6 months:
- AUGUST J. TROENDLE (CEO) has made 0 purchases and 15 sales selling 278,418 shares for an estimated $167,599,756.
- JESSE J GEIGER (President) has made 0 purchases and 4 sales selling 76,238 shares for an estimated $41,107,589.
- SUSAN E BURWIG (Exec. VP, Operations) has made 0 purchases and 3 sales selling 40,000 shares for an estimated $24,283,020.
- STEPHEN P EWALD (General Counsel & Corp. Secy.) sold 15,230 shares for an estimated $9,120,485
- ROBERT O. KRAFT sold 6,472 shares for an estimated $3,830,453
- FRED B JR DAVENPORT sold 5,972 shares for an estimated $3,474,987
- KEVIN M. BRADY (CFO & Treasurer) sold 3,000 shares for an estimated $1,771,050
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$MEDP Hedge Fund Activity
We have seen 401 institutional investors add shares of $MEDP stock to their portfolio, and 366 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AQR CAPITAL MANAGEMENT LLC added 324,293 shares (+31.6%) to their portfolio in Q4 2025, for an estimated $182,139,163
- WASATCH ADVISORS LP removed 277,657 shares (-30.0%) from their portfolio in Q4 2025, for an estimated $155,946,054
- MAWER INVESTMENT MANAGEMENT LTD. removed 239,472 shares (-37.0%) from their portfolio in Q4 2025, for an estimated $134,499,448
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 200,597 shares (-63.1%) from their portfolio in Q4 2025, for an estimated $112,665,305
- FMR LLC added 195,907 shares (+2507.1%) to their portfolio in Q4 2025, for an estimated $110,031,166
- FRANKLIN RESOURCES INC added 183,645 shares (+158.6%) to their portfolio in Q4 2025, for an estimated $103,144,214
- GOLDMAN SACHS GROUP INC added 166,654 shares (+92.4%) to their portfolio in Q4 2025, for an estimated $93,601,219
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$MEDP Revenue
$MEDP had revenues of $708.5M in Q4 2025. This is an increase of 32.03% from the same period in the prior year.
You can track MEDP financials on Quiver Quantitative's MEDP stock page.
$MEDP Congressional Stock Trading
Members of Congress have traded $MEDP stock 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $MEDP stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAVID TAYLOR has traded it 3 times. They made 2 purchases worth up to $30,000 on 02/26, 01/29 and 1 sale worth up to $15,000 on 01/16.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 0 purchases and 2 sales worth up to $65,000 on 01/15, 10/09.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$MEDP Analyst Ratings
Wall Street analysts have issued reports on $MEDP in the last several months. We have seen 2 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Jefferies issued a "Buy" rating on 02/13/2026
- TD Cowen issued a "Sell" rating on 10/24/2025
- Barclays issued a "Underweight" rating on 10/24/2025
- Mizuho issued a "Outperform" rating on 10/24/2025
To track analyst ratings and price targets for $MEDP, check out Quiver Quantitative's $MEDP forecast page.
$MEDP Price Targets
Multiple analysts have issued price targets for $MEDP recently. We have seen 8 analysts offer price targets for $MEDP in the last 6 months, with a median target of $530.5.
Here are some recent targets:
- Luke Sergott from Barclays set a target price of $500.0 on 03/06/2026
- Ryan Halsted from RBC Capital set a target price of $522.0 on 03/03/2026
- Charles Rhyee from TD Cowen set a target price of $419.0 on 02/18/2026
- David Windley from Jefferies set a target price of $560.0 on 02/13/2026
- Jailendra Singh from Truist Securities set a target price of $539.0 on 02/11/2026
- Michael Cherny from Leerink Partners set a target price of $485.0 on 02/11/2026
- Sean Dodge from BMO Capital set a target price of $600.0 on 11/13/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
